PMV Pharmaceuticals
PMVP
PMVP
120 hedge funds and large institutions have $614M invested in PMV Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.61% less ownership
Funds ownership: 134.13% → 127.52% (-6.6%)
21% less capital invested
Capital invested by funds: $775M → $614M (-$161M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
120
Holding in Top 10
4
Calls
$558K
Puts
$366K
Top Buyers
| 1 | +$5.11M | |
| 2 | +$3.83M | |
| 3 | +$2.7M | |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$2.5M |
| 5 |
Millennium Management
New York
|
+$1.91M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$15.2M | |
| 3 | -$5.24M | |
| 4 |
CC
Casdin Capital
New York
|
-$4.28M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.27M |